New decision aid aims to reduce surgery regret for rhinitis patients
NCT ID NCT07435714
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a printed decision aid that helps people with chronic hypertrophic rhinitis compare five surgical options. About 158 participants will either get standard counseling or the extra aid. Researchers will measure how certain patients feel about their choice and whether they regret it later.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- patient decision aid (printed tool to help patients weigh surgical options)
- What this could lead to
- If successful, this tool could help patients feel more confident and less regretful about their surgical choice.
- What could go wrong
- This is a small, early-stage behavioral study. The tool may not improve decision-making for everyone, and results may not apply to other settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 158 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with chronic hypertrophic rhinitis. * Outpatients or inpatients scheduled to undergo surgical intervention. * Aged 18 years or older and able to communicate in Chinese. Exclusion Criteria: * Presence of other structural nasal pathologies (e.g., nasal polyps, tumors). * Patients undergoing emergency surgery. * Individuals unable to live independently or fully comprehend the questionnaire content. * Individuals unable to complete the questionnaires.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Allergic rhinitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Shuang Ho Hospital
RECRUITINGNew Taipei City, 235, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a needle in the face tame allergy symptoms?
- Can AI make acupuncture more precise for allergy relief?
- Ancient herbal blend put to the test against hay fever
- Can a pinpoint pollen dose unmask allergy triggers?
- Can an antihistamine–steroid combo pill beat standard allergy meds?
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests